153 related articles for article (PubMed ID: 38834066)
21. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
[TBL] [Abstract][Full Text] [Related]
22. Structure of the TnsB transposase-DNA complex of type V-K CRISPR-associated transposon.
Tenjo-Castaño F; Sofos N; López-Méndez B; Stutzke LS; Fuglsang A; Stella S; Montoya G
Nat Commun; 2022 Oct; 13(1):5792. PubMed ID: 36184667
[TBL] [Abstract][Full Text] [Related]
23. Multiple adaptations underly co-option of a CRISPR surveillance complex for RNA-guided DNA transposition.
Park JU; Petassi MT; Hsieh SC; Mehrotra E; Schuler G; Budhathoki J; Truong VH; Thyme SB; Ke A; Kellogg EH; Peters JE
Mol Cell; 2023 Jun; 83(11):1827-1838.e6. PubMed ID: 37267904
[TBL] [Abstract][Full Text] [Related]
24. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
Swarts DC; van der Oost J; Jinek M
Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
[TBL] [Abstract][Full Text] [Related]
25. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic insights into transposon cleavage and integration by TnsB of ShCAST system.
Zeng T; Yin J; Liu Z; Li Z; Zhang Y; Lv Y; Lu ML; Luo M; Chen M; Xiao Y
Cell Rep; 2023 Jul; 42(7):112698. PubMed ID: 37379212
[TBL] [Abstract][Full Text] [Related]
27. Recruitment of CRISPR-Cas systems by Tn7-like transposons.
Peters JE; Makarova KS; Shmakov S; Koonin EV
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7358-E7366. PubMed ID: 28811374
[TBL] [Abstract][Full Text] [Related]
28. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
[TBL] [Abstract][Full Text] [Related]
29. DNA Targeting by a Minimal CRISPR RNA-Guided Cascade.
Hochstrasser ML; Taylor DW; Kornfeld JE; Nogales E; Doudna JA
Mol Cell; 2016 Sep; 63(5):840-51. PubMed ID: 27588603
[TBL] [Abstract][Full Text] [Related]
30. Temperature-Responsive Competitive Inhibition of CRISPR-Cas9.
Jiang F; Liu JJ; Osuna BA; Xu M; Berry JD; Rauch BJ; Nogales E; Bondy-Denomy J; Doudna JA
Mol Cell; 2019 Feb; 73(3):601-610.e5. PubMed ID: 30595438
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
32. Fanzor is a eukaryotic programmable RNA-guided endonuclease.
Saito M; Xu P; Faure G; Maguire S; Kannan S; Altae-Tran H; Vo S; Desimone A; Macrae RK; Zhang F
Nature; 2023 Aug; 620(7974):660-668. PubMed ID: 37380027
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of target site selection by type V-K CRISPR-associated transposases.
George JT; Acree C; Park JU; Kong M; Wiegand T; Pignot YL; Kellogg EH; Greene EC; Sternberg SH
bioRxiv; 2023 Jul; ():. PubMed ID: 37503092
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
35. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
Zheng W
Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
[TBL] [Abstract][Full Text] [Related]
36. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
[TBL] [Abstract][Full Text] [Related]
37. CRISPR transposons on the move.
Mougiakos I; Beisel CL
Cell Host Microbe; 2021 May; 29(5):675-677. PubMed ID: 33984272
[TBL] [Abstract][Full Text] [Related]
38. Structural basis of DNA targeting by a transposon-encoded CRISPR-Cas system.
Halpin-Healy TS; Klompe SE; Sternberg SH; Fernández IS
Nature; 2020 Jan; 577(7789):271-274. PubMed ID: 31853065
[TBL] [Abstract][Full Text] [Related]
39. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
Kim HM; Colaiácovo MP
Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
